Analyst Ratings for BridgeBio Pharma (BBIO) [Neutrals]

BBIO Rating Summary

BBIO Price Target Summary

* Over Last 12-Mos
  |   Expand Research on BBIO
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $81.29 (+37%) * Over Last 12-Mos
Rating Score: 9.2 / 10   Percentile Rank: 89%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
6/25/2020 BofA Securities
» Updated 1/5/2021
Geoff Meacham New Coverage Neutral
(N/A)
75.00
(44.00)
32.96
(59.35)
80.07% Details
Like BBIO Ratings? Also take a look at EIDX, PRTA, ON, PEGA

BBIO Ratings News